Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Study ID: NCT05873192
Start Date: 2025-09-30
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

ADT

Enzalutamid

Carcolor

Degarelix

Luprolide

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

Study ID: NCT05846789
Start Date: 2024-07-02
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

168

Intervention / Treatment

SOC Chemotherapy

Tocilizumab

Sponsor

Kathy Miller

Source: clinicaltrials.gov

Share:
Add to list

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Study ID: NCT05828589
Start Date: 2023-06-20
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

85

Intervention / Treatment

BGB-21447

Sponsor

Beigene

Source: clinicaltrials.gov

Share:
Add to list

MeFAMP for Imaging System a Amino Acid Transport in Primary and Metastatic Brain Tumors

Study ID: NCT05676489
Start Date: 2025-12-30
End Date: 2027-08-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

28

Intervention / Treatment

[F-18]MeFAMP PET

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

Study ID: NCT03465592
Start Date: 2018-05-01
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

39

Intervention / Treatment

Nivolumab

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

Study ID: NCT06548789
Start Date: 2024-09-16
End Date: 2030-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Prebiotic Xnack Packouts

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis

Study ID: NCT04562389
Start Date: 2021-03-11
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

350

Intervention / Treatment

Selinexor

Selinexor

Placebo

Rheops

Sponsor

Karyopharm Therapeutics Inc

Source: clinicaltrials.gov

Share:
Add to list

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Study ID: NCT06953089
Start Date: 2025-06-30
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

440

Intervention / Treatment

DB-1311/BNT324

Benah

DB-1305/BNT325

Sponsor

DualityBio Inc.

Source: clinicaltrials.gov

Share:
Add to list

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Study ID: NCT06477692
Start Date: 2024-11-14
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

ENI using IMRT with or without chemotherapy

Inrt

ENI

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Study ID: NCT06157892
Start Date: 2024-05-20
End Date: 2029-07-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

172

Intervention / Treatment

on Vedotin

tucatinib

Sponsor

Seagen, a wholly owned subsidiary of Pfizer

Source: clinicaltrials.gov

Share:
Add to list